Medicare “Phases In” Changes To Claims Appeals Process, Starting In May
This article was originally published in The Gray Sheet
Executive Summary
At least four Medicare-contracted entities will provide a second level of appeals for beneficiaries seeking to overturn claims redeterminations that carriers issue after December
You may also be interested in...
Medicare Appeals Rule Expedited By Visudyne Settlement; MCAC To Convene
CMS' Medicare Coverage Advisory Committee will review initial data from QLT, Inc.'s Phase III trial investigating Visudyne (verteporfin) ocular photodynamic therapy in age-related macular degeneration patients with occult lesions
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.